Literature DB >> 9195970

Interferon-gamma rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells.

W Ma1, P J Lehner, P Cresswell, J S Pober, D R Johnson.   

Abstract

Human cytotoxic T lymphocytes (CTL) recognize specific complexes of HLA class I molecules and peptides, which assemble when nascent class I molecules bind peptides transported from the cytoplasm into the endoplasmic reticulum by the heterodimeric transporter associated with antigen processing (TAP). Increased class I molecule expression on the cell surface increases the efficiency of CTL lysis. The kinetics of interferon (IFN)-gamma induction of TAP, peptide transport capacity, and HLA class I molecule expression was determined in endothelial cells, which are targets of CTL following transplantation or viral infection. TAP mRNAs are induced rapidly, increasing 20-fold (TAP1) or 10-fold (TAP2) by 12 h, whereas HLA class I mRNA is induced more slowly, increasing 10-fold in 24 h. TAP1 and TAP2 proteins are also induced rapidly, increasing 10-fold in 24 h, whereas HLA class I heavy chain proteins and surface expression increase more slowly. Peptide transport capacity in endothelial and HeLa cells increases within 6 h of IFN-gamma treatment, suggesting that the IFN-gamma-induced TAP heterodimers are functional. Therefore, the IFN-gamma-induced increase in TAP proteins is accompanied by an increased peptide transport capacity, which may be important in supporting the subsequent rise in HLA class I protein expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195970     DOI: 10.1074/jbc.272.26.16585

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells.

Authors:  P A MacAry; M Lindsay; M A Scott; J I Craig; J P Luzio; P J Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application.

Authors:  Margot J Pont; Willemijn Hobo; Maria W Honders; Simone A P van Luxemburg-Heijs; Michel G D Kester; Annemarie M van Oeveren-Rietdijk; Nicolaas Schaap; Hetty C de Boer; Cornelis A M van Bergen; Harry Dolstra; J H Frederik Falkenburg; Marieke Griffioen
Journal:  Haematologica       Date:  2015-06-11       Impact factor: 9.941

3.  Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.

Authors:  L Zhang; J S Pagano
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer.

Authors:  Agnes Ling; Anna Löfgren-Burström; Pär Larsson; Xingru Li; Maria L Wikberg; Åke Öberg; Roger Stenling; Sofia Edin; Richard Palmqvist
Journal:  Oncoimmunology       Date:  2017-08-07       Impact factor: 8.110

5.  Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis.

Authors:  O Ayalon; E A Hughes; P Cresswell; J Lee; L O'Donnell; R Pardi; J R Bender
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis.

Authors:  Nicholas K Arger; Melissa Ho; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-04-17       Impact factor: 3.415

7.  Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.

Authors:  K Riesbeck; A Billström; J Tordsson; T Brodin; K Kristensson; M Dohlsten
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface.

Authors:  Satyan S Kalkunte; Teddy F Mselle; Wendy E Norris; Charles R Wira; Charles L Sentman; Surendra Sharma
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.

Authors:  K B Hendil; S Khan; K Tanaka
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.

Authors:  Annette Fink; Niels A W Lemmermann; Dorothea Gillert-Marien; Doris Thomas; Kirsten Freitag; Verena Böhm; Vanessa Wilhelmi; Kurt Reifenberg; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2012-09-09       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.